5 news items
Repligen Corporation to Present at Upcoming June Investor Conferences
RGEN
22 May 24
that develops and commercializes highly innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing
Repligen Corporation to Present at Upcoming May Investor Conferences
RGEN
7 May 24
CorporationRepligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing
Repligen Reports First Quarter 2024 Financial Results
RGEN
1 May 24
from our October 2023 acquisition of Metenova AB, in line with our first quarter expectations for this mixing and drive train technology innovator
Repligen to Report First Quarter 2024 Financial Results
RGEN
17 Apr 24
innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs. We are "inspiring
Repligen Appoints Maggie A. Pax to Board of Directors
RGEN
19 Mar 24
. This includes eight years with Thermo Fisher Scientific, where, from 2016–2020, she served as Vice President, Strategy and Innovation for the clinical
- Prev
- 1
- Next